Four Times Daily Maintenance Dose for 96 Hours: Agonist and Antagonist Effects in Buprenorphine Treatment
Data Collection
Narcotic-Related Disorders+2
+ Mental Disorders
+ Opioid-Related Disorders
Treatment Study
Summary
Study start date: December 1, 1992
Actual date on which the first participant was enrolled.This study focuses on individuals who are on a daily maintenance dose of Buprenorphine. The main goal is to find out if taking four times their usual dose can last for 96 hours without any changes in its effects. This is important because it could potentially simplify treatment schedules and improve quality of life for those managing opioid dependence. The study is in its second phase, meaning it has already passed initial safety tests and is now looking at how well it works and its side effects.
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.Treatment Study
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Any sex
Biological sex of participants that are eligible to enroll.From 21 to 51 Years
Range of ages for which participants are eligible to join.Healthy volunteers not allowed
If individuals who are healthy and do not have the condition being studied can participate.Conditions
Pathology
Criteria
Please contact site for information.
Study Plan
Find out more about all the medication administered in this study, their detailed description and what they involve.Study Objectives
Primary Objectives
Study Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.This study has 1 location